Why the storm will end for this specialist sector
In theory, the biotech sector has plenty going for it from an investment perspective, given that companies are aiming to develop drugs that are badly needed by people all around the world. However, it is a volatile part of the market, as the past couple of years have proven. Joining Kyle to explain why biotech has…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.